Ichor Biologics is a biotech firm that specializes in the design of monoclonal antibodies for infectious diseases and toxin-related disorders. Established by scientists and entrepreneurs dedicated to fighting global health crises, the company targets novel therapeutic solutions.

Bengaluru-based Bugworks Research, founded in 2014, is tackling antibiotic resistance with cutting-edge drug development. Led by Dr. Anand Anandkumar, the startup is creating new broad-spectrum antibiotics—some of the first in decades. Backed by global organizations like CARB-X and the Gates Foundation, Bugworks is putting India on the map in the fight against deadly superbugs.